|
A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects Clinical Trials Facts presented on Clinical Trials Search is not designed to be a substitute for certified medical advice, travels to or professional assistance by using a genuine doctor. We aren't mDs. Always consult your physician about A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects Clinical research trials and A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects health trials occur in a lot of of cities throughout the US. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the potency of new does drugs. The role of the studies / undertakings is to figure out specific human healthcare questions. Clinical trials are a popular manner for mDs, government agencies, and private sector companies to locate treatments for all sorts of conditions, including A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects. A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects Clinical Trials and other clinical trials permit volunteers to get medical treatment choices before they are available to the general public. Many times the test subjects get professional assistance for free of charge, and occasionally they are compensated for their time. Sometimes there is a cost for a A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects clinical trial. Human subjects often get the best healthcare possible for their A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, medical hazards (perhaps life-threatening), and/or the treatment being ineffectual. Trials are federally governed with exacting guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects  A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
For Condition: Hypocalcemia
Status: Recruiting
Sponsor(s): Abbott Laboratories ,
Synopsis: A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Factorial Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - ICU patients APACHE III score between 70 - 150 at screening and within 24 hours of enrollment and a whold blood ionized calcium level less than 0.90 mmol/L or corrected whole blook calcium level less than or equal to 7.5 mg/dL. Exclusion Criteria: - Serum creatinine greater than 2.5 mg/dL
Total Enrollment: 45
Location and Contact Information:
Overall Study Official:
JoelMelnick, Study Director, Abbott Laboratories
Denver Health Medical Center *Recruiting*
Denver, Colorado, 80204
United States
Recruiting Ivor Douglas
Florida Hospital *Recruiting*
Orlando, Florida, 32803
United States
Recruiting H.B. Karunaratne 407-894-4474
Outcomes Research Institute *Recruiting*
Hudson, Florida, 34667
United States
Recruiting Rita Plyer 727-863-4069
Harborview Medical Center *No longer recruiting*
Seattle, Washington, 98104
United States
No longer recruiting
Baylor University Medical Center *Recruiting*
Dallas, Texas, 75204
United States
Recruiting Renee Gale 214-820-9907
University of Rochester Medical Center *Recruiting*
Rochester, New York, 14642
United States
Recruiting David Kaufman 585-273-1911
University of Chicago *Recruiting*
Chicago, Illinois, 60637
United States
Recruiting Sharon Trevino 773-702-4222
Central Baptist Hospital Clinical Research Center *Recruiting*
Lexington, Kentucky, 40503
United States
Recruiting Lori Poynter 859-260-6295
Additional Information:
Study ID Numbers: M01-395;
Study Start Date:
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00053378
Other Hypocalcemia Studies:
1. A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
2. Resistance to Vitamin D or Parathyroid Hormone
3. Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study
4. Studies of Elevated Parathyroid Activity
5. Studies with Vitamin D
Related Studies:
Other Hypocalcemia Clinical Trials
Other Colorado Clinical Trials
Other Denver Clinical Trials
A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
|
|
|
|
|
|
|
|
